Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1887 clinical trials
A Study of ERAS-007 in Patients With Advanced or Metastatic Solid Tumors

dose and schedule of ERAS-007 monotherapy. To evaluate antitumor activity of ERAS-007 in various solid tumors.

  • 0 views
  • 17 Jul, 2021
  • 6 locations
Phase I of Eribulin and Oral Irinotecan for Relapsed or Refractory Solid Tumors

This Phase I trial will establish the recommended phase II dose of eribulin in combination with fixed doses of oral irinotecan in adolescents and young adults with relapsed or refractory solid

  • 2 views
  • 08 Nov, 2020
  • 1 location
Phase 1/2a Study of MPB-1734 in Patients With Advanced Solid Tumors

This is a first-in-human (FIH), multicenter, open-label, uncontrolled, Phase 1/2a study with dose escalation in patients with advanced solid tumors (Part 1) and cohorts of up to 15 patients per

  • 0 views
  • 10 May, 2022
  • 1 location
A Phase 1 Study to Evaluate JS019 in Advanced Solid Tumors or Lymphomas

This is a phase 1 clinical study to evaluate the safety, tolerability, pharmacokinetics and preliminary efficacy of JS019 as monotherapy in patients with advanced malignant solid tumors

  • 0 views
  • 27 May, 2022
  • 1 location
A Phase I Study of BPI-16350 in Patients With Advanced Solid Tumor

This was an open-label Phase I study. The primary objective of the study was to assess safety, tolerability, efficacy, and pharmacokinetic characteristics of BPI-16350 in different dose groups.

  • 0 views
  • 08 Jul, 2022
  • 1 location
A Phase 1 Study of BPI-28592 in Subjects With Advanced Solid Tumors

This is an open-labe Phase I study of BPI-28592 for the treatment of patients with solid tumors

solid tumor
  • 0 views
  • 19 Apr, 2022
  • 6 views
  • 21 Oct, 2022
  • 1 location
Phase 1/2 Study of OBI-999 in Patients With Advanced Solid Tumors

activity profile of the RP2D of OBI-999 in patients with advanced solid tumors.

  • 0 views
  • 04 Oct, 2022
  • 4 locations
First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors

recurrent solid tumors or metastatic solid tumors where curative or standard treatment options have been exhausted

breast cancer
carcinoma
primary cancer
  • 0 views
  • 04 Oct, 2022
  • 1 location
Dose Escalation/Dose Expansion Study of YBL-006 in Patients With Advanced Solid Tumors

This is a Phase 1, open-label, multicenter, dose-escalation/dose-expansion study of YBL-006, in participants with Advanced Solid Tumors. This multicenter study will be conducted in approximately

  • 0 views
  • 07 Oct, 2021
  • 8 locations